Uremic Toxins and Vascular Calcification-Missing the Forest for All the Trees
Related Experiment Video
Updated: Dec 7, 2025

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Nikolas Rapp1, Pieter Evenepoel2, Peter Stenvinkel3
1Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, 6229 ER Maastricht, The Netherlands.
Insights
Uremic toxins contribute to vascular calcification in chronic kidney disease (CKD) by altering vascular smooth muscle cells. Further research is needed to understand and combat this cardiovascular risk factor.
Area of Science:
- Nephrology
- Cardiology
- Vascular Biology
Background:
- Cardiorenal syndrome involves detrimental interactions between the kidneys and vasculature.
- Reduced kidney function creates a uremic environment that promotes vascular calcification, increasing cardiovascular risk.
- Key biological mechanisms include oxidative stress, inflammation, and cellular senescence.
Purpose of the Study:
- To review the current understanding of how uremic toxins contribute to vascular calcification in CKD.
- To highlight the need for further investigation into the vasotoxic effects of uremic retention molecules.
- To identify potential therapeutic targets for reducing vascular calcification.
Main Methods:
- This review synthesizes existing literature on uremic toxins and vascular calcification.
- It examines experimental evidence regarding the biological mechanisms involved.
- The review identifies limitations in current research, including experimental heterogeneity.
Main Results:
- Uremic toxins alter vascular smooth muscle cell phenotype, promoting calcification.
- Evidence linking specific uremic toxins to vascular calcification is currently limited and fragmented.
- Existing research often lacks standardization, hindering comparative analysis.
Conclusions:
- Uremic toxins play a significant role in the pathogenesis of vascular calcification in CKD.
- There is a critical need for standardized experimental approaches and collaborative efforts.
- Solving the puzzle of uremic vascular calcification requires integrated basic and clinical research.
Abstract:
The cardiorenal syndrome relates to the detrimental interplay between the vascular system and the kidney. The uremic milieu induced by reduced kidney function alters the phenotype of vascular smooth muscle cells (VSMC) and promotes vascular calcification, a condition which is strongly linked to cardiovascular morbidity and mortality. Biological mechanisms involved include generation of reactive oxygen species, inflammation and accelerated senescence. A better understanding of the vasotoxic effects of uremic retention molecules may reveal novel avenues to reduce vascular calcification in CKD. The present review aims to present a state of the art on the role of uremic toxins in pathogenesis of vascular calcification. Evidence, so far, is fragmentary and limited with only a few uremic toxins being investigated, often by a single group of investigators. Experimental heterogeneity furthermore hampers comparison. There is a clear need for a concerted action harmonizing and standardizing experimental protocols and combining efforts of basic and clinical researchers to solve the complex puzzle of uremic vascular calcification.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Urinary Tract Calculi I: Introduction
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Urinary Tract Calculi III: Medical Management
Acute Kidney Injury II: Pathophysiology

